Table 1.
GRADE criteria | Original | Challenge | Specifications or adaptions |
---|---|---|---|
Study type/methodological quality | NRS start as “low quality” of evidencea | Data on harms from RCTs is often insufficient and thus it is advisable to consider NRS | NRS start as “high quality” of evidence if rated as low risk for confounding and selection bias |
Imprecision (binary outcomes) |
Usually, 95% of CIs of relative effects are used 95%CI overlaps decision threshold (e.g. null effect) → rating down one level 95%CI includes appreciable harm and benefit → rating down two levels |
Harms are often rare events and rare in the included studies despite large sample sizes. In the case of rare events 95% CIs of relative effects can be misleading. | Imprecision is assessed based on absolute effects |
Publication bias/missing results in the synthesis | Rating down for publication bias | For harms selective dissemination would result in underestimation of harms | Rating up for publication bias |
Large magnitude of effect | Rating up if RR >2 (<0.5) | Harms are usually less affected by confounding by indication | Rating up if RR >1.67 (<0.60) |
Originally not used | Subgroup effects | Harms are often subgroup-specific but analysis within subgroups is underpowered | Rating up if there is a statistically significant subgroup effect from a well-designed subgroup analysis |
aWhen using the ROBINS-I tool NRS usually start as high quality of evidence and an adaption is not necessary